The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Update

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the target of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 6,600 shares, a decrease of 71.9% from the March 31st total of 23,500 shares. Based on an average daily trading volume, of 26,600 shares, the days-to-cover ratio is currently 0.2 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Trading Down 0.2 %

Shares of NASDAQ:CGABL traded down $0.03 during midday trading on Monday, reaching $17.11. The company had a trading volume of 874 shares, compared to its average volume of 24,928. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 1-year low of $16.43 and a 1-year high of $20.85. The company has a fifty day simple moving average of $17.46 and a two-hundred day simple moving average of $18.38.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Saturday, February 15th. Investors of record on Saturday, February 1st were paid a $0.2891 dividend. This is an increase from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. This represents a $1.16 annualized dividend and a yield of 6.76%. The ex-dividend date was Friday, January 31st.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.